Corpus Intelligence IC Memo — AVERA DELLS AREA HOSPITAL 2026-04-26 11:19 UTC
IC Memo — AVERA DELLS AREA HOSPITAL
Investment Committee Memorandum | SD | 23 beds | Grade D | EBITDA uplift $900K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

AVERA DELLS AREA HOSPITAL

CCN 431331 | MINNEHAHA, SD | 23 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

AVERA DELLS AREA HOSPITAL is a 23-bed rural/critical access in MINNEHAHA, SD with $12.2M in net patient revenue and a 14.7% operating margin. The hospital serves a payer mix of 81.8% Medicare, 0.4% Medicaid, and 17.8% commercial.

Thesis: Turnaround. Our ML models identify $900K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 14.7% to 22.1% (+739bps).

Net Revenue HCRIS$12.2M
Current EBITDA COMPUTED$1.8M
Operating Margin COMPUTED14.7%
Occupancy HCRIS9.0%
Revenue / Bed COMPUTED$530K
Net-to-Gross HCRIS57.0%
Distress Probability ML62.5%

2. Market Context & Competitive Position

63
SD Hospitals
-3.2%
State Median Margin
41
Comparable Hospitals

SD has 63 Medicare-certified hospitals with a median operating margin of -3.2%. The target's margin of 14.7% places it above the state median. Among 41 size-comparable peers (12-46 beds), the median margin is -3.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-46), prioritizing same-state peers. 41 hospitals in the comp set.

HospitalStateBedsRevenueMargin
AVERA DELLS AREA HOSPITAL (Target)SD23$12.2M14.7%
SIOUX FALLS SPECIALTY HOSPITALSD33$138.8M31.7%
AVERA SACRED HEART HOSPITALSD42$123.1M-1.9%
AVERA QUEEN OF PEACESD25$122.9M-5.8%
MONUMENT HEALTH SPEARFISH HOSPSD27$116.6M1.9%
SIOUXLAND SURGERY CENTERSD38$105.7M40.1%
BLACK HILLS SURGICAL HOSPITAL SD26$91.1M15.3%
HURON REGIONAL MEDICAL CENTERSD25$49.4M-5.9%
MONUMENT HEALTH STURGIS REGIONSD25$39.1M-3.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $900K (739bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$256K+210bp18mo
Cost to Collect4.5%2.5%$244K+200bp12mo
Denial Rate Reduction12.0%6.5%$243K+199bp12mo
A/R Days Reduction5200.0%3800.0%$148K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+8bp6mo

5. EBITDA Bridge

Net Collection Rate
$256K
Cost to Collect
$244K
Denial Rate Reduction
$243K
A/R Days Reduction
$148K
Clean Claim Rate
$10K
Total EBITDA Uplift$900K
Current EBITDA$1.8M
+ RCM Uplift+$900K
Pro Forma EBITDA$2.7M
Current Margin14.7%
Pro Forma Margin22.1%
WC Released (1x)$467K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.8M$20.8M7.56x49.9%
Base (11x exit)10.0x11.0x$2.8M$23.8M8.64x53.9%
Bull Case9.0x11.0x$2.5M$27.6M11.16x62.0%
Bull (12x exit)9.0x12.0x$2.5M$30.9M12.46x65.6%
Bear Case11.0x10.0x$3.0M$15.4M5.09x38.5%
Bear (11x exit)11.0x11.0x$3.0M$17.9M5.92x42.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 81.8% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 9.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 62.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 41 hospitals with 12-46 beds
  • Same-state prioritization (n=42)
  • Comp margins: P25=-9.0% / P50=-3.1% / P75=8.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.